State Street’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.18M Buy
4,391,111
+125,144
+3% +$262K ﹤0.01% 2654
2025
Q1
$7.27M Sell
4,265,967
-344,529
-7% -$587K ﹤0.01% 2718
2024
Q4
$23.3M Sell
4,610,496
-153,659
-3% -$776K ﹤0.01% 2141
2024
Q3
$25.9M Buy
4,764,155
+1,895,529
+66% +$10.3M ﹤0.01% 2064
2024
Q2
$13.8M Buy
2,868,626
+1,655,896
+137% +$7.95M ﹤0.01% 2368
2024
Q1
$3.77M Buy
1,212,730
+59,939
+5% +$186K ﹤0.01% 3042
2023
Q4
$3.27M Buy
1,152,791
+26,713
+2% +$75.9K ﹤0.01% 3133
2023
Q3
$3.3M Buy
1,126,078
+86,798
+8% +$254K ﹤0.01% 3117
2023
Q2
$2.97M Buy
1,039,280
+378,485
+57% +$1.08M ﹤0.01% 3234
2023
Q1
$2.04M Buy
660,795
+169,810
+35% +$525K ﹤0.01% 3337
2022
Q4
$1.04M Buy
490,985
+72,372
+17% +$153K ﹤0.01% 3544
2022
Q3
$1.37M Buy
418,613
+571
+0.1% +$1.86K ﹤0.01% 3523
2022
Q2
$1.34M Buy
418,042
+176,839
+73% +$568K ﹤0.01% 3576
2022
Q1
$1.7M Buy
241,203
+171,526
+246% +$1.21M ﹤0.01% 3629
2021
Q4
$505K Buy
+69,677
New +$505K ﹤0.01% 4022